PHG

Business Context and Reporting Period

Company: Koninklijke Philips Electronics N.V.
Filing Type: Form 20-F (Annual Report)
Reporting Period: Fiscal year ended December 31, 2001
Business Overview: A global multinational engaged in lighting, consumer electronics, domestic appliances, personal care, components, semiconductors, and medical systems. The company operates in approximately 150 countries with 160 production sites and employed approximately 189,000 people at year-end 2001.

Key Financial Metrics (2001)

Note: Figures presented in EUR millions unless otherwise noted. US$ figures are provided where available in the source text.

Key Ratios (2001):
- Operating Margin: -4.2% (vs 11.3% in 2000)
- Return on Equity (ROE): -12.8% (vs 53.5% in 2000)
- Net Debt to Group Equity Ratio: 27:73 (vs 12:88 in 2000)

Material Changes vs. Prior Period

• Revenue Decline: Sales decreased by approximately 14.6% (EUR 5.5 billion) compared to 2000, dropping from EUR 37.86 billion to EUR 32.34 billion.
• Profitability Reversal: The company swung from a net profit of EUR 9.6 billion in 2000 to a net loss of EUR 2.6 billion in 2001. Operating income turned negative (loss of EUR 1.37 billion) from a profit of EUR 4.28 billion.
• Debt Increase: Long-term debt more than doubled, rising from EUR 2.28 billion in 2000 to EUR 6.59 billion in 2001. Total debt reached EUR 7.87 billion.
• Impairment Charges: A significant impairment charge of EUR 526 million was recorded in 2001 related to equity and security investments deemed to have an other-than-temporary decline in value.
• Workforce Reduction: Total employees decreased from 219,429 in 2000 to 188,643 in 2001, reflecting strategic restructuring.

Guidance, Outlook, and Risks

Management Commentary & Strategy:
- Strategic Refocusing: Philips continues to streamline its portfolio, reducing the number of businesses and focusing on core areas: Lighting, Consumer Electronics, Domestic Appliances, Components, Semiconductors, and Medical Systems.
- Medical Systems Growth: Significant acquisitions in 2001 (Agilent Healthcare Solutions and Marconi's Medical Systems) strengthened the division to a No. 2 global position in medical imaging.
- Accounting Change: Philips confirmed its intention to apply full US GAAP to financial reporting starting in 2002, moving away from Dutch GAAP to ensure comparability with industry peers.

Risks and Contingencies:
- Market Risks: Exposure to economic slowdowns, changes in consumer spending, and currency fluctuations (Euro vs. US Dollar).
- Legal Proceedings: Ongoing proceedings regarding environmental problems, including Superfund sites in the US. Management does not currently believe these will have a material effect on financial position.
- Debt Ratings: Risk of credit rating downgrades which could negatively influence borrowing capacity and increase financing costs.
- Impairment Sensitivity: Future results could be significantly impacted by changes in assumptions regarding goodwill, intangible assets, and long-lived assets.

Investor Verification Checklist

• US GAAP Transition: Verify the impact of the switch from Dutch GAAP to US GAAP on 2002 financial reporting, specifically regarding goodwill amortization and discontinued operations.
• Impairment Details: Review the specific nature of the EUR 526 million impairment charge and the valuation of remaining equity investments.
• Debt Structure: Analyze the composition of the increased long-term debt (EUR 6.6 billion) and the terms of the USD 2.5 billion revolving credit facility.
• Medical Systems Integration: Assess the post-merger integration progress of Agilent and Marconi acquisitions and their contribution to cash flow.
• Restructuring Costs: Confirm the extent of remaining restructuring provisions and the timeline for achieving the targeted cost reductions.